E. Eric Tokat

target

Medivation Inc.

bidder

Pfizer

value n/a

3 dealmakers

target

Kite Pharma

bidder

Gilead Sciences

£9,302m

24 dealmakers

target

Antelliq Group

bidder

Merck Animal Health

£2,922m

30 dealmakers

target

Spark Therapeutics

bidder

Roche Holdings

£3,291m

29 dealmakers

target

Clementia Pharmaceuticals

bidder

IPSEN

£995m

41 dealmakers

target

Peloton Therapeutics

bidder

Merck & Co

£824m

42 dealmakers

target

Genomic Health

bidder

Exact Sciences

£2,260m

43 dealmakers

target

Achillion Pharmaceuticals

bidder

Alexion Pharmaceuticals

£732m

21 dealmakers

target

SYNTHORX

bidder

Sanofi

£1,902m

50 dealmakers

target

Arqule

bidder

Merck Kgaa

£2,054m

62 dealmakers

target

Merck & Co (women’s Health, Trusted Legacy Brands, And Biosimilars Businesses)

bidder

Institutional Investors

£5,390m

17 dealmakers

target

Pionyr Immunotherapeutics

bidder

Gilead Sciences

£221m

24 dealmakers

target

Eidos Therapeutics

bidder

Bridgebio Pharma

£757m

16 dealmakers

target

Biospecifics Technologies Corp

bidder

Endo Pharmaceuticals

£487m

26 dealmakers

target

Velosbio

bidder

Merck & Co

£2,116m

55 dealmakers

target

Prevail Therapeutics

bidder

Eli Lilly And Company

£778m

36 dealmakers

target

Cantel Medical Corp

bidder

Steris

£2,647m

45 dealmakers

target

Pandion Therapeutics

bidder

Merck & Co

£1,308m

28 dealmakers

target

Constellation Pharmaceuticals

bidder

Morphosys

£1,198m

58 dealmakers

target

Translate Bio

bidder

Sanofi

£2,302m

52 dealmakers

target

Immunovant Sciences

bidder

Roivant Sciences

£143m

12 dealmakers

target

Vividion Therapeutics

bidder

Bayer

£1,437m

47 dealmakers

target

Trillium Therapeutics

bidder

Pfizer

£1,658m

55 dealmakers

target

Sanifit Therapeutics

bidder

Vifor Pharma

£314m

14 dealmakers

target

Lengo Therapeutics

bidder

Blueprint Medicines

£348m

57 dealmakers

target

Arena Pharmaceuticals

bidder

Pfizer

£5,052m

36 dealmakers

target

Amunix Pharmaceuticals

bidder

Sanofi

£756m

36 dealmakers

target

REVIRAL

bidder

Pfizer

£401m

27 dealmakers

target

Checkmate Pharmaceuticals

bidder

REGENERON

£191m

62 dealmakers

target

Biohaven Pharmaceutical Holding Company

bidder

Pfizer

£9,417m

45 dealmakers

target

MIROBIO

bidder

Gilead Sciences

£333m

42 dealmakers

target

Forma Therapeutics

bidder

Novo Nordisk

£944m

65 dealmakers

target

AKOUOS

bidder

Eli Lilly And Company

£539m

22 dealmakers

target

Djs Antibodies

bidder

Abbvie

£227m

37 dealmakers

target

Famy Life Sciences

bidder

VIATRIS

£659m

58 dealmakers

target

Imago Biosciences

bidder

Merck & Co

£1,135m

42 dealmakers

target

Tmunity Therapeutics

bidder

Kite Pharma

value n/a

29 dealmakers

target

Amryt Pharma

bidder

Chiesi Farmaceutici

£1,223m

44 dealmakers

target

Albireo Pharma

bidder

IPSEN

£786m

29 dealmakers

target

Cincor Pharma

bidder

Astrazeneca

£1,487m

79 dealmakers

target

Provention Bio

bidder

Sanofi

£2,408m

76 dealmakers

target

Prometheus Biosciences

bidder

Merck & Co

£8,698m

50 dealmakers

target

Bellus Health

bidder

Glaxosmithkline

£1,614m

17 dealmakers

target

VECTIVBIO

bidder

Ironwood Pharmaceuticals

£803m

65 dealmakers

target

Chinook Therapeutics

bidder

Novartis

£2,781m

75 dealmakers

target

Pfizer (preclinical Gene Therapy Programs)

bidder

Alexion Pharmaceuticals

£779m

14 dealmakers

target

Decibel Therapeutics

bidder

REGENERON

£167m

24 dealmakers

target

Inversago Pharma

bidder

Novo Nordisk

£843m

12 dealmakers

target

Point Biopharma

bidder

Eli Lilly And Company

£1,152m

40 dealmakers

target

Gracell Biotechnologies

bidder

Astrazeneca

£971m

34 dealmakers

target

RAYZEBIO

bidder

Bristol Myers Squibb Company

£3,228m

36 dealmakers

target

Mariana Oncology

bidder

Novartis

£1,400m

39 dealmakers

target

EXSCIENTIA

bidder

Recursion Pharmaceuticals

£539m

11 dealmakers